Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline F Thorn

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
JAMA|November 16, 2006
Comparison of health status between the United States and EnglandCaroline F Thorn
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Differential glucocorticoid enhancement of the cytokine-driven transcriptional activation of the human acute phase serum amyloid A genes, SAA1 and SAA2Caroline F Thorn, Alexander S Whitehead
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 1, 2003
Differential transcription of the mouse acute phase serum amyloid A genes in response to pro-inflammatory cytokinesCaroline F Thorn, Alexander S Whitehead
Pharmacogenomics|March 31, 2010
Pharmacogenomics and bioinformatics: PharmGKBCaroline F Thorn, Teri E Klein, Russ B Altman
European Journal of Immunology|August 26, 2003
Tissue-specific regulation of the human acute-phase serum amyloid A genes, SAA1 and SAA2, by glucocorticoids in hepatic and epithelial cellsCaroline F Thorn, Zhi-Yong Lu, Alexander S Whitehead
Pharmacogenetics and Genomics|November 10, 2009
PharmGKB summary: very important pharmacogene information for angiotensin-converting enzymeCaroline F Thorn, Teri E Klein, Russ B Altman
Pharmacogenetics and Genomics|June 11, 2009
Codeine and morphine pathwayCaroline F Thorn, Teri E Klein, Russ B Altman
Methods in Molecular Biology (Clifton, N.J.)|August 16, 2005
PharmGKB: the pharmacogenetics and pharmacogenomics knowledge baseCaroline F Thorn, Teri E Klein, Russ B Altman
Pharmacogenetics and Genomics|November 11, 2010
PharmGKB summary: very important pharmacogene information for PTGS2Caroline F Thorn, Tilo Grosser, Teri E Klein, et al.
Pharmacogenetics and Genomics|October 13, 2011
PharmGKB summary: very important pharmacogene information for CYP1A2Caroline F Thorn, Eleni Aklillu, Teri E Klein, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
JAMA|November 16, 2006
Comparison of health status between the United States and EnglandCaroline F Thorn
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2002
Differential glucocorticoid enhancement of the cytokine-driven transcriptional activation of the human acute phase serum amyloid A genes, SAA1 and SAA2Caroline F Thorn, Alexander S Whitehead
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 1, 2003
Differential transcription of the mouse acute phase serum amyloid A genes in response to pro-inflammatory cytokinesCaroline F Thorn, Alexander S Whitehead
Pharmacogenomics|March 31, 2010
Pharmacogenomics and bioinformatics: PharmGKBCaroline F Thorn, Teri E Klein, Russ B Altman
European Journal of Immunology|August 26, 2003
Tissue-specific regulation of the human acute-phase serum amyloid A genes, SAA1 and SAA2, by glucocorticoids in hepatic and epithelial cellsCaroline F Thorn, Zhi-Yong Lu, Alexander S Whitehead
Pharmacogenetics and Genomics|November 10, 2009
PharmGKB summary: very important pharmacogene information for angiotensin-converting enzymeCaroline F Thorn, Teri E Klein, Russ B Altman
Pharmacogenetics and Genomics|June 11, 2009
Codeine and morphine pathwayCaroline F Thorn, Teri E Klein, Russ B Altman
Methods in Molecular Biology (Clifton, N.J.)|August 16, 2005
PharmGKB: the pharmacogenetics and pharmacogenomics knowledge baseCaroline F Thorn, Teri E Klein, Russ B Altman
Pharmacogenetics and Genomics|November 11, 2010
PharmGKB summary: very important pharmacogene information for PTGS2Caroline F Thorn, Tilo Grosser, Teri E Klein, et al.
Pharmacogenetics and Genomics|October 13, 2011
PharmGKB summary: very important pharmacogene information for CYP1A2Caroline F Thorn, Eleni Aklillu, Teri E Klein, et al.
Pageof 5